204 related articles for article (PubMed ID: 11095446)
1. Alterations in the p16INK4a/CDKN2A tumor suppressor gene in gastrinomas.
Serrano J; Goebel SU; Peghini PL; Lubensky IA; Gibril F; Jensen RT
J Clin Endocrinol Metab; 2000 Nov; 85(11):4146-56. PubMed ID: 11095446
[TBL] [Abstract][Full Text] [Related]
2. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas.
Goebel SU; Heppner C; Burns AL; Marx SJ; Spiegel AM; Zhuang Z; Lubensky IA; Gibril F; Jensen RT; Serrano J
J Clin Endocrinol Metab; 2000 Jan; 85(1):116-23. PubMed ID: 10634374
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors: an analysis of p16/MTS1 tumor suppressor gene inactivation.
Muscarella P; Melvin WS; Fisher WE; Foor J; Ellison EC; Herman JG; Schirmer WJ; Hitchcock CL; DeYoung BR; Weghorst CM
Cancer Res; 1998 Jan; 58(2):237-40. PubMed ID: 9443399
[TBL] [Abstract][Full Text] [Related]
4. Multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas in Japan.
Kawamura J; Shimada Y; Komoto I; Okamoto H; Itami A; Doi R; Fujimoto K; Kosugi S; Imamura M
Oncol Rep; 2005 Jul; 14(1):47-52. PubMed ID: 15944766
[TBL] [Abstract][Full Text] [Related]
5. A personal experience with pancreatic and duodenal neuroendocrine tumors.
Jordan PH
J Am Coll Surg; 1999 Nov; 189(5):470-82. PubMed ID: 10549736
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of insulin-like growth factor I and/or its receptor in gastrinomas is associated with low curability, increased growth, and development of metastases.
Furukawa M; Raffeld M; Mateo C; Sakamoto A; Moody TW; Ito T; Venzon DJ; Serrano J; Jensen RT
Clin Cancer Res; 2005 May; 11(9):3233-42. PubMed ID: 15867218
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome.
Alexander HR; Fraker DL; Norton JA; Bartlett DL; Tio L; Benjamin SB; Doppman JL; Goebel SU; Serrano J; Gibril F; Jensen RT
Ann Surg; 1998 Aug; 228(2):228-38. PubMed ID: 9712569
[TBL] [Abstract][Full Text] [Related]
8. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
9. Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness.
Goebel SU; Iwamoto M; Raffeld M; Gibril F; Hou W; Serrano J; Jensen RT
Cancer Res; 2002 Jul; 62(13):3702-10. PubMed ID: 12097278
[TBL] [Abstract][Full Text] [Related]
10. Sonic hedgehog and pancreatic-duodenal homeobox 1 expression distinguish between duodenal and pancreatic gastrinomas.
Fendrich V; Ramerth R; Waldmann J; Maschuw K; Langer P; Bartsch DK; Slater EP; Ramaswamy A; Rothmund M
Endocr Relat Cancer; 2009 Jun; 16(2):613-22. PubMed ID: 19240184
[TBL] [Abstract][Full Text] [Related]
11. Comparison study of gastrinomas between gastric and non-gastric origins.
Huang SF; Kuo IM; Lee CW; Pan KT; Chen TC; Lin CJ; Hwang TL; Yu MC
World J Surg Oncol; 2015 Jun; 13():202. PubMed ID: 26077245
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity of chromosome 1q in gastrinomas: occurrence and prognostic significance.
Chen YJ; Vortmeyer A; Zhuang Z; Huang S; Jensen RT
Cancer Res; 2003 Feb; 63(4):817-23. PubMed ID: 12591732
[TBL] [Abstract][Full Text] [Related]
13. INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.
Hui R; Macmillan RD; Kenny FS; Musgrove EA; Blamey RW; Nicholson RI; Robertson JF; Sutherland RL
Clin Cancer Res; 2000 Jul; 6(7):2777-87. PubMed ID: 10914724
[TBL] [Abstract][Full Text] [Related]
14. X-chromosome loss of heterozygosity frequently occurs in gastrinomas and is correlated with aggressive tumor growth.
Chen YJ; Vortmeyer A; Zhuang Z; Gibril F; Jensen RT
Cancer; 2004 Apr; 100(7):1379-87. PubMed ID: 15042671
[TBL] [Abstract][Full Text] [Related]
15. Recurrence after surgical resection of gastrinoma: who, when, where and why?
Maire F; Sauvanet A; Couvelard A; Rebours V; Vullierme MP; Lebtahi R; Hentic O; Belghiti J; Hammel P; Lévy P; Ruszniewski P
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):368-74. PubMed ID: 22410712
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological characteristics of duodenal microgastrinomas.
Imamura M; Kanda M; Takahashi K; Shimada Y; Miyahara T; Wagata T; Hashimoto M; Tobe T; Soga J
World J Surg; 1992; 16(4):703-9; discussion 709-10. PubMed ID: 1357832
[TBL] [Abstract][Full Text] [Related]
17. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome.
Ruszniewski P; Amouyal P; Amouyal G; Grangé JD; Mignon M; Bouché O; Bernades P
Surgery; 1995 Jun; 117(6):629-35. PubMed ID: 7778027
[TBL] [Abstract][Full Text] [Related]
18. Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma.
Bartsch DK; Waldmann J; Fendrich V; Boninsegna L; Lopez CL; Partelli S; Falconi M
Br J Surg; 2012 Sep; 99(9):1234-40. PubMed ID: 22864882
[TBL] [Abstract][Full Text] [Related]
19. Possible primary lymph node gastrinoma: occurrence, natural history, and predictive factors: a prospective study.
Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
Ann Surg; 2003 May; 237(5):650-7; discussion 657-9. PubMed ID: 12724631
[TBL] [Abstract][Full Text] [Related]
20. Deletions of RDINK4/ARF enhancer in gastrinomas and nonfunctioning pancreatic neuroendocrine tumors.
Poi MJ; Drosdeck J; Frankel WL; Muscarella P; Li J
Pancreas; 2014 Oct; 43(7):1009-13. PubMed ID: 25003221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
